Ben Tre Pharmaceutical JSC (HOSE:DBT)

Vietnam flag Vietnam · Delayed Price · Currency is VND
10,400
+50 (0.48%)
At close: Feb 27, 2026
-7.27%
Market Cap 232.85B
Revenue (ttm) 860.40B
Net Income (ttm) 14.03B
Shares Out 21.97M
EPS (ttm) 638.88
PE Ratio 16.59
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 237
Average Volume 12,004
Open 10,850
Previous Close 10,350
Day's Range 10,400 - 10,850
52-Week Range 9,907 - 12,150
Beta 0.53
RSI 46.82
Earnings Date Feb 3, 2026

About HOSE:DBT

Ben Tre Pharmaceutical Joint Stock Company manufactures, distributes, and sells pharmaceutical products in Vietnam and internationally. The company offers drugs in injectable, infusion, pill, and lotion forms. The company provides products covering various therapeutic areas, including central nervous system, respiratory system, endocrinology, obstetrics and gynecology, anti-allergic, cardiovascular, antibiotics, anti-fungal, anti-viral, musculoskeletal, vitamins and minerals, digestive, hepatobiliary and urinary, pain relief, fever reducer, ant... [Read more]

Industry Pharmaceutical Preparations
Founded 1963
Employees 684
Stock Exchange Ho Chi Minh Stock Exchange
Ticker Symbol DBT
Full Company Profile

Financial Performance

In 2025, HOSE:DBT's revenue was 860.40 billion, a decrease of -0.92% compared to the previous year's 868.41 billion. Earnings were 14.03 billion, an increase of 4.07%.

Financial Statements

News

There is no news available yet.